The haemochromatosis mutations do not modify the clinical picture of thalassaemia major in patients regularly transfused and chelated.
Iron overload is the main cause of morbidity and mortality in patients with thalassaemia major. In order to establish if the presence of the mutations recently described in the haemochromatosis gene affects the severity of iron overload in thalassaemia patients, we compared the prevalence of mutations C282Y and H63D in 216 young adults regularly transfused and chelated in North-Eastern Italy with the frequency found in a group of blood donors from the same area. For each patient, mean serum ferritin over the last 3 years, liver iron concentration, and the presence of diabetes, hypogonadism and heart disease, were considered. The frequency of the C282Y allele was 1.9% in patients with thalassaemia major and 2.3% in blood donors (P=ns). The frequency of the H63D allele was 16.2% in patients with thalassaemia major and 15.3% in blood donors (P=ns). When age, liver iron concentration and mean yearly serum ferritin levels were compared in patients with and without mutations C282Y and H63D, no significant differences were found. Also, the prevalence of iron-induced complications was not significantly different between patients carrying or not carrying the mutations. The presence of the HH mutations does not seem to influence the degree of iron overload and its consequences in regularly transfused and chelated patients with thalassaemia major.
Borgna-Pignatti
C
C
Department of Clinical and Experimental Medicine, University of Ferrara, Italy.
Solinas
A
A
Bombieri
C
C
Micciolo
R
R
Gamberini
M R
MR
De Stefano
P
P
De Menis
E
E
Pignatti
P F
PF
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D015913:Chelation Therapy; D005260:Female; D006432:Hemochromatosis / Q000150:complications / Q000235:genetics*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D009154:Mutation; D017086:beta-Thalassemia / Q000150:complications / Q000235:genetics / Q000628:therapy*